JENNIFER ASHLEY: Open Payments
NPI 1598417511 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 30 payments from 6 companies in 2025. Trend: 2023 $723 · 2024 $387 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $272 |
| Vanda Pharmaceuticals Inc. | 4 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Janssen Pharmaceuticals, Inc | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
Products named: VRAYLAR, FANAPT, CAPLYTA, INVEGA SUSTENNA, REXULTI, Qelbree, HETLIOZ.
Industry payments across AR — which companies pay providers there.
